NasdaqCM:RNXT
NasdaqCM:RNXTBiotechs

RenovoRx (NASDAQ:RNXT) Is Revolutionizing Cancer Treatment

Stock_Research_Today
RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment. Using its Trans-Arterial Micro-Perfusion (TAMP™) platform, the company aims to solve a major issue in cancer care: how to get strong doses of chemo directly to the tumor while avoiding harmful side effects throughout the body.